glp 1 tirzepatide zepbound GLP-1 Pricing & Plans Tirzepatide Tops Semaglutide for Weight

Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S

Conversely, this trend heralds a potential boom for producers of health-oriented products like protein shakes and meal replacements, indicating a realignment of consumer preferences towards weight-management foods

By Mrinalika Roy and Sriparna Roy April 20 (Reuters) - The surging popularity of GLP-1 weight-loss drugs is quietly reshaping the $40 billion U.S

If all newly eligible patients received semaglutide, Medicare Part D spending could increase by$34 billion to $145 billion each year, according to new research.

Moreover, the baseline gut microbiome predicted changes in glycohemoglobin for semaglutide and empagliflozin users

This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes, obesity, and heart or blood vessel disease